###### Article summary

Article focus
=============

-   The perceived mild nature of the 2009 H1N1 pandemic is largely based on the observed outcomes of disease in urban centres and densely populated areas.

-   Estimates for the transmissibility of this virus suggest that the novel H1N1 was less transmissible than the 1918 pandemic strain.

-   These findings may not reflect the true nature of disease in remote and isolated communities.

Key messages
============

-   Transmissibility of the novel H1N1 pandemic appears to have been significantly higher in some remote and isolated Canadian communities compared to that in urban centres.

-   Our findings for indigenous communities with the type of attack rate and transmissibility of influenza infection tantamount to the 1918 pandemic is a cause for alarm, and underscore the need for nuanced and community-specific intervention measures with improved access to healthcare and critical infrastructures.

Strengths and limitations of this study
=======================================

-   The differential severity of the pandemic in these regions may be explained partly by differential transmissibility.

-   Comparison of H1N1 transmissibility in several remote and isolated communities with an urban centre in Canada.

-   Limitations of this study include the simplifying assumption of homogeneity in the population interactions; and the lack of specific data, which precludes the use of more complex models with network structure or age-stratified populations. The simple model structure does not elucidate the specific mechanisms driving increased transmissibility in the communities studied here.

Introduction {#s1}
============

Early outbreaks of the 2009 H1N1 influenza pandemic displayed variable degrees of incidence, apparently higher attack rates and more severe disease outcomes in several remote and isolated communities in Canada.[@R1] [@R2] Epidemiological data collected during the first wave of H1N1 pandemic indicate disproportionately higher rates of hospitalisation and intensive care unit (ICU) admission in these communities. For instance, hospitalisation rates in Nunavut and northern Manitoba were 2.44 and 1.27 per 1000 population, respectively, which are significantly higher than the corresponding rates for Winnipeg (0.13) or the province of Ontario (0.033). Similar differences are evident from data regarding ICU admission rates, which were higher for Nunavut (0.20) and northern Manitoba (0.16) than those for Winnipeg (0.032) and Ontario (0.0056), per 1000 population. The differential prevalence of predisposing health conditions including diabetes, pregnancy and morbid obesity, has received considerable attention as explicators of severe outcomes of H1N1 pandemic in rural and urban communities in Canada.[@R2] The high rates of hospitalisation and ICU admission within these remote regions could be linked to both transmissibility of the disease and to the prevalence of factors predisposing to more severe outcomes in infected individuals.

An important index of transmissibility for a communicable disease is the basic reproduction number (R~0~) that represents the number of secondary infections generated by a single infected case in an entirely susceptible population.[@R3] Early published literature for the transmissibility of pandemic H1N1 infection provides a range of 1.2−1.8 for R~0~,[@R4; @R5; @R6; @R7] mainly in large urban settings, suggesting that the novel H1N1 strain was less transmissible than the 1918--1919 pandemic virus for which R~0~ has been estimated in the range 1.8−3.0.[@R8] However, early estimates may not apply in remote and isolated communities that have distinct demographic characteristics, as well as distinct environmental (built or natural) conditions. We sought to evaluate differential transmissibility of H1N1 in five distinct population settings in Canada: a remote/isolated community in the Burntwood health region of northern Manitoba, three remote/isolated communities in Nunavut, and compare them with the largest urban area (ie, the Winnipeg health region) in Manitoba. Communities in Nunavut as well as several communities in northern Manitoba would be considered remote and/or isolated communities[@R9] and many of these geographic areas have predominantly Aboriginal populations (eg, 85% of the Nunavut population and 76% of the northern Manitoba region self-identify as Aboriginal).[@R10]

Material and methods {#s2}
====================

To estimate plausible ranges for R~0~, we employed a discrete time epidemic model, and fitted to infection curves inferred from collected data for laboratory-confirmed cases of H1N1 infection during the first wave of the 2009 pandemic. Details of data and estimation procedure are described below.

Case data {#s2a}
---------

We obtained the daily number of laboratory-confirmed cases of pandemic H1N1 influenza (in which the cases were reported based on the earliest date of symptom onset, initial care, specimen collection, hospital admission, or ICU admission) for the period of 3 May to 5 August 2009, for each community under study. A laboratory-confirmed case was reported as an individual with ILI or severe respiratory illness who tested positive for pandemic H1N1 influenza A virus by real-time reverse-transcriptase PCR (RT-PCR) or viral culture. These data were collected and provided by Manitoba Health, and the Nunavut Department of Health and Social Services.

The model {#s2b}
---------

We considered a homogeneous mixing structure for the model in which individuals are identified by their epidemiological status as susceptible (S), exposed but not yet infectious (E), infectious (I) and recovered (R). Exposed state refers to the period of time following transmission of infection during which the newly infected person cannot transmit the disease and symptoms are absent before developing clinical disease. Assuming that the reduction in the number of susceptibles is small during the early stages of the outbreak (ie, , where S~0~ is the initial number of susceptibles),[@R11] the number of infections at time t is given by[@R12]

where σ and γ are the average duration of exposed and infectious stages, I~0~ is the initial number of infectious cases (in this case, the number of cases in datasets generated through sampling described below), and R~0~ is the basic reproduction number. The expression [(1)](#BMJOPEN2012001614M1){ref-type="disp-formula"} describes the exponential growth of epidemic spread following disease outset. We estimated R~0~ by fitting I(t) to infection curves during the exponential phase of epidemic growth.

Model parameters {#s2c}
----------------

The values of exposed and infectious periods were taken from estimated ranges in the published literature specific to the 2009 pandemic, with a fixed exposed period of 1 day.[@R13] We sampled the duration of infectiousness from a log-normal distribution with the mean of 3.38 days.[@R11] Using a common heuristic, that the generation times can be estimated as the sum of the exposed period and half of the duration of infectiousness,[@R14] leads to a mean generation times of 2.69 days. Considering a size-biased sampling approach, where primary cases with many secondary cases are assigned a greater weight,[@R15] the mean of generation times includes an additional term given by variance multiplied by half of the duration of infectious period. This gives a slightly higher mean generation times of 2.78 days, which lies within the estimated range for pandemic H1N1.[@R16; @R17; @R18]

Sampling {#s2d}
--------

To determine the variability in R~0~, we generated 1000 datasets for case counts on each day through sampling from a Poisson distribution. We considered the absolute difference between the number of laboratory-confirmed cases on day j and day j* *+ 1 as the mean of distribution. To generate new datasets, we added (subtracted if the difference was negative) the sampled value to the number of reported cases on day j to obtain new cases on day j* *+ 1. This sampling approach captures a higher variability in the number of observed cases during the epidemic course and a smaller variability at the onset or towards the end of epidemic.[@R19] To create an infection curve for each dataset, first we sampled an infectious period for each case from a log-normal distribution with the scale parameter a=1.192 and shape parameter b=0.05.[@R11] We assumed that the infectious period was initiated one day before the case was confirmed (reported date).[@R11] [@R12] This effectively means that every case was on the infection curve I(t) for its sampled duration of infectiousness ([figures 1](#BMJOPEN2012001614F1){ref-type="fig"} and [2](#BMJOPEN2012001614F2){ref-type="fig"}).

![Infection curves for remote and isolated communities, generated through sampling procedure. The black circled-curves in the time courses correspond to the infection curves generated from the reported data, and grey curves are generated from sampled data.](bmjopen2012001614f01){#BMJOPEN2012001614F1}

![Infection curve for Winnipeg health region, generated through sampling procedure. The black circled-curves in the time courses correspond to the infection curves generated from the reported data, and grey curves are generated from sampled data.](bmjopen2012001614f02){#BMJOPEN2012001614F2}

R~0~ estimation {#s2e}
---------------

Since the reproduction number reflects only the growth rate during the early stages of the epidemic, estimating R~0~ is sensitive to the time period chosen for fitting the model to the data.[@R20] For a fit with very short timelines following the onset of the outbreak (establishment phase), the uncertainty in estimates of R~0~ will be high. On the other hand, fitting the model using data that extend beyond the epidemic peak will result in underestimating R~0~, through the influence of several factors, including widespread implementation of public health measures and an increase in herd immunity, which may in turn invalidate the assumption . In order to minimise these effects, we obtained the turning points of the outbreaks following the initial exponential growth phase, beyond which the epidemic will no longer have exponential growth. We performed fitting from the date at which the first laboratory-confirmed case was identified, up to one day before the turning point for each infection curve, to ensure that R~0~ estimates reflect the initial growth phase of the outbreak. Turning point for each dataset was obtained through fitting the Richards model to the cumulative number of daily counts in each infection curve.[@R21] [@R22] Assuming that K represents the cumulative number of daily cases for an infection curve I(t) (generated through sampling method described above), the first turning point t~m~ was obtained by solving the equation , where c is the deviation parameter estimated using the method of least squares through curve fitting.[@R23] This equation holds at the inflection point for the solution of the Richards model. We then estimated R~0~ by fitting I(t) in [equation (1)](#BMJOPEN2012001614M1){ref-type="disp-formula"} to the generated infection curves from the date of the first laboratory case until . The mean values and 95% CIs were obtained from the R~0~ distributions generated through the fitting procedure.

Results {#s3}
=======

The infection curves generated for fitting are illustrated in [figures 1](#BMJOPEN2012001614F1){ref-type="fig"} and [2](#BMJOPEN2012001614F2){ref-type="fig"}. The mean estimate of R~0~ for a northern community in Manitoba ([figure 1](#BMJOPEN2012001614F1){ref-type="fig"}a) is 2.26 (95% CI 1.57 to 3.75), which is higher than the estimate for Winnipeg health region with the mean value of 1.57 (95% CI 1.35 to 1.87). We obtained considerably higher estimates for the mean values of R~0~ for other communities in the territory of Nunavut ([figures 1](#BMJOPEN2012001614F1){ref-type="fig"}b--d): 3.91 (95% CI 3.08 to 4.87); 2.03 (95% CI 1.50 to 3.19); and 2.45 (95% CI 1.68 to 3.44). Mean values of R~0~ stay above previous estimates for H1N1 transmission in larger communities and urban centres.[@R4; @R5; @R6; @R7] While estimated R~0~ ranges considerably overlap, outbreaks in Nunavut appear to have been driven by somewhat higher transmissibility that is comparable or higher than that of the 1918 pandemic.[@R8] We further estimated R~0~ by creating a single dataset for northern communities in Manitoba and Nunavut. The mean value of R~0~ was 2.21 (95% CI 1.98 to 2.50), providing a significant difference (Wilcoxon signed-rank test: p\<0.001) when compared with R~0~ estimates for the Winnipeg health region.

Discussion {#s4}
==========

Determining the variability in transmissibility of a novel disease in populations with different demographics (eg, age structure, household composition, and housing density) is crucial for identifying the within-community factors that have the greatest influence on disease spread and (by changing the total number of infections) its severity. Our results suggest that more severe outcomes observed in the 2009 influenza A H1N1 pandemic in remote and isolated communities[@R2] may have been due to differential transmissibility of infection, resulting in more rapid epidemic spread and larger numbers of individuals affected at northern latitudes.[@R24]

Estimates of transmissibility could play an important role in determining the most effective utilisation of public health interventions, in particular when resources are scarce. It is important to note that R~0~ is effectively an *exponent* that determines both epidemic growth properties at the early stage of disease outset, the final size of an epidemic in the absence of interventions and the fraction of individuals who need to be vaccinated to achieve herd immunity.[@R25] For example, the expected relative final size of an epidemic with an R~0~ of 2.7 is 25% larger in the absence of intervention than an epidemic with an R~0~ of 1.8; and to attain an immune herd (ie, critical vaccination level: 1--1/R~0~), the absolute fraction of the population vaccinated must be 19% higher in the population with the higher R~0~. This has important public health implications for vaccination programmes and suggests that transmissibility is an important consideration in prioritising the allocation of limited health resources.

The mechanisms underlying the differential transmissibility of a pathogen in these Canadian communities are unclear, but could be related to the effectiveness of available disease control programmes, environmental factors including the prevalence of low-quality housing,[@R26] exposure to indoor air pollutants, lack of access to clean water and also to differences in demographic characteristics, crowding and mixing patterns. For example, the average number of persons per household in the northern Manitoba region is 3.6, which is 44% greater than the mean size of 2.5 persons per household in Winnipeg as the largest urban centre in the same province.[@R27] [@R28] The average number of people per household in Nunavut is 3.8, which is higher than both northern Manitoba and Winnipeg;[@R10] this may therefore account for a higher rate of secondary household transmission, which is known as a major route for the spread of influenza infection in the wider community.[@R29; @R30; @R31] In addition, age has been recognised as an important parameter for the spread of disease with higher rates of infectious contacts among schoolchildren and younger adults. There are also differences in the age profiles of the populations studied here with other urban centres. For example, the average age in the northern Manitoba region is 24 and in Nunavut is 23,[@R10] which is approximately 15--16 years younger than the average age (38.7) in Winnipeg.[@R26] [@R27] In Nunavut, only 2.7% of the population is greater than 65 years of age and 34% of the population is less than 15 years of age.[@R10] Although older age has been associated with a higher risk of severe outcomes during seasonal influenza epidemics, pandemics (eg, 1918, 1957) are generally characterised by high rates of morbidity and mortality among younger adults,[@R32] [@R33] as has also been documented for the 2009 H1N1 pandemic.[@R34] Moreover, serological studies have shown the existence of cross-reactive antibody responses for individuals older than 50 years of age due to prior exposure to similar viruses,[@R35] which may reflect a reduced likelihood of H1N1 infection in older populations. As was observed in other geographic regions,[@R36] in Manitoba the 2009 pandemic predominantly affected young adults and children in both spring and fall waves ([figure 3](#BMJOPEN2012001614F3){ref-type="fig"}).

![Heatmaps represent the daily number of laboratory confirmed cases of H1N1 infection for various age-groups during the first (a) and second (b) waves of the 2009 pandemic in the province of Manitoba. Barplots represent the cumulative number of laboratory confirmed cases for different age-groups during the first (a) and second (b) waves of the 2009 pandemic in the province of Manitoba.](bmjopen2012001614f03){#BMJOPEN2012001614F3}

In populations with low mean age (such as Nunavut), the buffering effect of pre-existing immunity in older individuals is less pronounced, which may contribute to higher transmissibility of the virus. In remote and isolated communities in Canada, climate, healthcare capacity in the community, socioeconomic status, health status, presence of vulnerable groups (eg, children \<5 years of age, immunocompromised, and pregnant women), limited numbers of healthcare workers in the community, equipment and facilities, medical transportation and other critical infrastructure such as housing also play a role in determining differential epidemic impact.[@R37]

The model employed in this study is subject to limitations, including the simplifying assumption of homogeneity in the population interactions. Some of the limitations are imposed by the lack of specific data, which precludes the use of more complex models with network structure or age-stratified populations. The simple model structure does not elucidate the specific mechanisms driving increased transmissibility in these communities. However, empirical evidence to support the observation of increased transmissibility in these communities clearly demonstrates the need for ongoing research in order to identify the specific mechanisms. Due to uncertainties in the level of pre-existing immunity and its distribution in different age segments of the population, we did not include the effect of immune responses in our model. However, considering prior immunity[@R38] we would expect to estimate greater values for R~0~ compared to when the entire population is assumed to be susceptible. Finally, our model considers these communities without considering travel or interactions with other population settings in the same region. It is possible that some influenza cases were undiagnosed and thus not captured in surveillance data; this would lead us to underestimate the transmissibility of the virus, making our estimates 'lower bound' estimates. We would expect underreporting to be less likely in the first wave of the pandemic (the time period that we examined) than the second wave, as individuals with influenza-like illness symptoms were encouraged to seek medical care, especially in remote and isolated communities. In the absence of data for the true burden of the disease, we used laboratory-confirmed case counts, which may be subject to biases due to differential rates of testing between different age groups, different geographic regions and over time. However, it is difficult to assess the magnitude and direction of such biases. Data available for this study did not provide any relevant information on other potential confounders that could be included in our estimation model. Despite these limitations, our results suggest that there is indeed a considerable difference between the reproduction numbers of H1N1 outbreaks in remote and isolated communities and urban centers. Further investigation is required to explore the underlying mechanistic reasons for this differential transmissibility, which could determine population-specific factors that should be integrated into the process of public health decision making for future planning, in the face of an emerging infectious disease.
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